159 related articles for article (PubMed ID: 37123046)
1. Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma.
Oldan JD; Giglio BC; Smith E; Zhao W; Bouchard DM; Ivanovic M; Lee YZ; Collichio FA; Meyers MO; Wallack DE; Abernethy-Leinwand A; Long PK; Trembath DG; Googe PB; Kowalski MH; Ivanova A; Ezzell JA; Nikolaishvili-Feinberg N; Thomas NE; Wong TZ; Ollila DW; Li Z; Moschos SJ
Oncoimmunology; 2023; 12(1):2204753. PubMed ID: 37123046
[TBL] [Abstract][Full Text] [Related]
2. The expanding roles of 1-methyl-tryptophan (1-MT): in addition to inhibiting kynurenine production, 1-MT activates the synthesis of melatonin in skin cells.
Moreno AC; Clara RO; Coimbra JB; Júlio AR; Albuquerque RC; Oliveira EM; Maria-Engler SS; Campa A
FEBS J; 2013 Oct; 280(19):4782-92. PubMed ID: 23879623
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies.
Juhász C; Nahleh Z; Zitron I; Chugani DC; Janabi MZ; Bandyopadhyay S; Ali-Fehmi R; Mangner TJ; Chakraborty PK; Mittal S; Muzik O
Nucl Med Biol; 2012 Oct; 39(7):926-32. PubMed ID: 22444239
[TBL] [Abstract][Full Text] [Related]
4. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas.
Bosnyák E; Kamson DO; Guastella AR; Varadarajan K; Robinette NL; Kupsky WJ; Muzik O; Michelhaugh SK; Mittal S; Juhász C
Neuro Oncol; 2015 Sep; 17(9):1284-92. PubMed ID: 26092774
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy.
Fujiwara Y; Kato S; Nesline MK; Conroy JM; DePietro P; Pabla S; Kurzrock R
Cancer Treat Rev; 2022 Nov; 110():102461. PubMed ID: 36058143
[TBL] [Abstract][Full Text] [Related]
6. Increased tryptophan transport in epileptogenic dysembryoplastic neuroepithelial tumors.
Alkonyi B; Mittal S; Zitron I; Chugani DC; Kupsky WJ; Muzik O; Chugani HT; Sood S; Juhász C
J Neurooncol; 2012 Apr; 107(2):365-72. PubMed ID: 22048879
[TBL] [Abstract][Full Text] [Related]
7. Effects of IDO1 and TDO2 inhibition on cognitive deficits and anxiety following LPS-induced neuroinflammation.
Imbeault S; Goiny M; Liu X; Erhardt S
Acta Neuropsychiatr; 2020 Feb; 32(1):43-53. PubMed ID: 31753057
[TBL] [Abstract][Full Text] [Related]
8. Etiological classification of depression based on the enzymes of tryptophan metabolism.
Fukuda K
BMC Psychiatry; 2014 Dec; 14():372. PubMed ID: 25540092
[TBL] [Abstract][Full Text] [Related]
9. The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1.
Panfili E; Mondanelli G; Orabona C; Gargaro M; Volpi C; Belladonna ML; Rossini S; Suvieri C; Pallotta MT
Front Immunol; 2023; 14():1134551. PubMed ID: 37122718
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.
Guastella AR; Michelhaugh SK; Klinger NV; Fadel HA; Kiousis S; Ali-Fehmi R; Kupsky WJ; Juhász C; Mittal S
J Neurooncol; 2018 Sep; 139(2):239-249. PubMed ID: 29667084
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of tryptophan metabolism in the nontumoral hemisphere in patients with malignant glioma.
Kamson DO; Lee TJ; Varadarajan K; Robinette NL; Muzik O; Chakraborty PK; Snyder M; Barger GR; Mittal S; Juhász C
J Nucl Med; 2014 Oct; 55(10):1605-10. PubMed ID: 25189339
[TBL] [Abstract][Full Text] [Related]
12. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.
Chen PW; Mellon JK; Mayhew E; Wang S; He YG; Hogan N; Niederkorn JY
Exp Eye Res; 2007 Nov; 85(5):617-25. PubMed ID: 17870068
[TBL] [Abstract][Full Text] [Related]
13. Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib.
Riess C; Schneider B; Kehnscherper H; Gesche J; Irmscher N; Shokraie F; Classen CF; Wirthgen E; Domanska G; Zimpfer A; Strüder D; Junghanss C; Maletzki C
Front Immunol; 2020; 11():55. PubMed ID: 32117235
[TBL] [Abstract][Full Text] [Related]
14. Improved Radiosynthesis and Biological Evaluations of L- and D-1-[
Xin Y; Cai H
Mol Imaging Biol; 2017 Aug; 19(4):589-598. PubMed ID: 27815661
[TBL] [Abstract][Full Text] [Related]
15. Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice.
Aslamkhan AG; Xu Q; Loughlin A; Vu H; Pacchione S; Bhatt B; Garfinkel I; Styring TG; LaFranco-Scheuch L; Pearson K; Reynolds S; Li N; Zhou H; Miller JR; Solban N; Bass A; Glaab WE
Toxicol Appl Pharmacol; 2020 Nov; 406():115216. PubMed ID: 32871117
[TBL] [Abstract][Full Text] [Related]
16. IDO Targeting in Sarcoma: Biological and Clinical Implications.
Nafia I; Toulmonde M; Bortolotto D; Chaibi A; Bodet D; Rey C; Velasco V; Larmonier CB; Cerf L; Adam J; Le Loarer F; Savina A; Bessede A; Italiano A
Front Immunol; 2020; 11():274. PubMed ID: 32194552
[TBL] [Abstract][Full Text] [Related]
17. In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1.
Zitron IM; Kamson DO; Kiousis S; Juhász C; Mittal S
Cancer Biol Ther; 2013 Apr; 14(4):333-9. PubMed ID: 23358471
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond.
Muller AJ; Manfredi MG; Zakharia Y; Prendergast GC
Semin Immunopathol; 2019 Jan; 41(1):41-48. PubMed ID: 30203227
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumour immunity induces aberrant peptide presentation in melanoma.
Bartok O; Pataskar A; Nagel R; Laos M; Goldfarb E; Hayoun D; Levy R; Körner PR; Kreuger IZM; Champagne J; Zaal EA; Bleijerveld OB; Huang X; Kenski J; Wargo J; Brandis A; Levin Y; Mizrahi O; Alon M; Lebon S; Yang W; Nielsen MM; Stern-Ginossar N; Altelaar M; Berkers CR; Geiger T; Peeper DS; Olweus J; Samuels Y; Agami R
Nature; 2021 Feb; 590(7845):332-337. PubMed ID: 33328638
[TBL] [Abstract][Full Text] [Related]
20. Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function.
Too LK; Li KM; Suarna C; Maghzal GJ; Stocker R; McGregor IS; Hunt NH
Behav Brain Res; 2016 Oct; 312():102-17. PubMed ID: 27316339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
